Protease inhibitory activity of secretory leukocyte protease inhibitor ameliorates murine experimental colitis by protecting the intestinal epithelial barrier-Reference-Cited by-同舟云学术

Protease inhibitory activity of secretory leukocyte protease inhibitor ameliorates murine experimental colitis by protecting the intestinal epithelial barrier

Published:2021-08-17 Issue:10 Volume:26 Page:807-822
ISSN:1356-9597
Container-title:Genes to Cells
language:en
Short-container-title:Genes Cells

Author:

Ozaka Sotaro¹²^ORCID,Sonoda Akira¹²^ORCID,Ariki Shimpei¹²,Kamiyama Naganori¹,Hidano Shinya¹,Sachi Nozomi¹,Ito Kanako²,Kudo Yoko²,Minata Mizuki¹,Saechue Benjawan¹,Dewayani Astri³,Chalalai Thanyakorn¹,Soga Yasuhiro¹,Takahashi Yuya¹,Fukuda Chiaki¹,Mizukami Kazuhiro¹²,Okumura Ryu⁴,Kayama Hisako⁴,Murakami Kazunari²,Takeda Kiyoshi⁴,Kobayashi Takashi¹^ORCID

Affiliation:

1. Department of Infectious Disease Control Faculty of Medicine Oita University Yufu Japan

2. Department of Gastroenterology Faculty of Medicine Oita University Yufu Japan

3. Department of Anatomy, Histology, and Pharmacology Faculty of Medicine Universitas Airlangga Surabaya Indonesia

4. Laboratory of Immune Regulation Department of Microbiology and Immunology Graduate School of Medicine WPI Immunology Frontier Research Center Osaka University Suita Japan

Funder

Japan Society for the Promotion of Science

Taiju Life Social Welfare Foundation

Publisher

Wiley

Subject

Cell Biology,Genetics

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/gtc.12888

Reference51 articles.

1. Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn’s disease using terminal restriction fragment length polymorphism analysis

2. Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing